StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$5.27+0.19 (+3.74%)

Close on Nov 20, 2026Market cap $410.77MP/E –Yield –

CorMedix free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CorMedix's free cash flow for the twelve months ending Jun 30, 2026 was $250.42M, up 723.5% year over year. For fiscal 2025 it was $172.79M. The highest annual figure on record is $172.79M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$172.79M–
FY2024Dec 31, 2024-$50.73M–
FY2023Dec 31, 2023-$38.74M–
FY2022Dec 31, 2022-$24.58M–
FY2021Dec 31, 2021-$22.58M–
FY2020Dec 31, 2020-$22.08M–
FY2019Dec 31, 2019-$15.09M–
FY2018Dec 31, 2018-$23.75M–
FY2017Dec 31, 2017-$28.74M–
FY2016Dec 31, 2016-$22.32M–
FY2015Dec 31, 2015-$12.54M–
FY2014Dec 31, 2014-$6.35M–
FY2013Dec 31, 2013-$3.65M–
FY2012Dec 31, 2012-$2.28M–
FY2011Dec 31, 2011-$6.30M–
FY2010Dec 31, 2010-$3.68M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$85.68M+185.9%
Q1 FY2026Mar 31, 2026$41.65M+111.1%
Q4 FY2025Dec 31, 2025$92.74M–
Q3 FY2025Sep 30, 2025$30.35M–
Q2 FY2025Jun 30, 2025$29.97M–
Q1 FY2025Mar 31, 2025$19.73M–
Q4 FY2024Dec 31, 2024-$5.63M–
Q3 FY2024Sep 30, 2024-$13.66M–
Q2 FY2024Jun 30, 2024-$14.07M–
Q1 FY2024Mar 31, 2024-$17.37M–
Q4 FY2023Dec 31, 2023-$11.04M–
Q3 FY2023Sep 30, 2023-$8.71M–
Q2 FY2023Jun 30, 2023-$8.58M–
Q1 FY2023Mar 31, 2023-$10.41M–
Q4 FY2022Dec 31, 2022-$6.28M–
Q3 FY2022Sep 30, 2022-$6.07M–
Q2 FY2022Jun 30, 2022-$5.47M–
Q1 FY2022Mar 31, 2022-$6.75M–
Q4 FY2021Dec 31, 2021-$6.50M–
Q3 FY2021Sep 30, 2021-$6.28M–
Q2 FY2021Jun 30, 2021-$3.10M–
Q1 FY2021Mar 31, 2021-$6.70M–
Q4 FY2020Dec 31, 2020-$6.01M–
Q3 FY2020Sep 30, 2020-$7.33M–
Q2 FY2020Jun 30, 2020-$758.41K-571.2%
Q1 FY2020Mar 31, 2020-$7.98M–
Q4 FY2019Dec 31, 2019-$3.89M–
Q3 FY2019Sep 30, 2019-$3.97M–
Q2 FY2019Jun 30, 2019$160.95K–
Q1 FY2019Mar 31, 2019-$7.39M–
Q4 FY2018Dec 31, 2018-$7.20M–
Q3 FY2018Sep 30, 2018-$5.12M–
Q2 FY2018Jun 30, 2018-$4.34M–
Q1 FY2018Mar 31, 2018-$7.09M–
Q4 FY2017Dec 31, 2017-$7.40M–
Q3 FY2017Sep 30, 2017-$6.82M–
Q2 FY2017Jun 30, 2017-$7.75M–
Q1 FY2017Mar 31, 2017-$6.76M–
Q4 FY2016Dec 31, 2016-$6.50M–
Q3 FY2016Sep 30, 2016-$6.60M–

More CorMedix figures

See a number that looks wrong?